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ABSTRACT
Pheochromocytomas have been described in association with vascular abnormalities like renal artery stenosis. 
A 48-year-old man was admitted to our hospital with the complaints of headache, sweating, anxiety, dizziness, 
nausea, vomiting and hypertension. For last several days, he was having a dull aching abdominal pain. Abdominal 
computed tomography (CT) revealed the presence of a left adrenal pheochromocytoma. An inferior vena cava 
(IVC) venogram via the right jugular vein demonstrated occlusion of the IVC inferior to the right atrium. 
Surgical removal of pheochromocytoma was done, followed by anticoagulant treatment for IVC thrombosis, 
initially with subcutaneous low molecular weight heparin, and then with oral warfarin, resulting in restoration 
of patency. To the best of our knowledge, the occurrence of pheochromocytoma in IVC thrombosis has not 
been reported so far from India. Possible mechanisms of such an involvement are discussed.
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scans.[4] Surgical resection of the tumor mass is the 
definitive treatment.[5]
Thrombosis of the inferior vena cava (IVC) has comparable 
etiological factors to lower limb deep venous thrombosis.[6] 
Hypercoagulability related to hematological or neoplastic 
abnormalities, venous stasis secondary to extraluminal 
pressure from tumors or inflammatory processes, and vessel 
injury due to trauma have all been implicated as primary 
mechanism in the pathophysiology of IVC thrombosis.[6] 
However, its association with pheochromocytoma in Indian 
subjects has not been reported till date. We report the case 
of a patient who presented with pheochromocytoma and 
IVC thrombosis.
CASE REPORT
A 48-year-old man was admitted to our hospital with 
complaints of headache, sweating, anxiety, dizziness, nausea 
and vomiting. He also had dull aching abdominal pain. 
He was a nonsmoker with no significant family history. 
Clinical Case Report Based Study
INTRODUCTION
Pheochromocytomas are rare catecholamine producing 
tumors arising from chromaffine cells in the sympatho 
adrenal system. Its prevalence is estimated at 0.1% to 
0.6%.  [1] They secrete various catecholamines, predominantly 
norepinephrine, and epinephrine to small extent.[2] These 
catecholamines are responsible for the manifestations 
with sustained or paroxysmal symptoms.[2] Diagnosis is 
established by measuring metanephrines in the urine or 
blood.[3] Localization of the tumor is done using computed 
tomography (CT) or magnetic resonance imaging (MRI) 
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Figure 3: IVC venogram showing multiple filling defects indicating 
occlusion of the inferior vena cava inferior to the right atrium. There is 
distal enlargement of inferior vena cava
There was no history of risk factors for hypercoagulable 
state. The patient was 164 cm tall and weighed 57 kg. On 
physical examination, there were no café au lait spots or 
neurofibromas. His resting pulse rate was 100 beats/min. 
The patient’s blood pressure was 240/150 mmHg. Bilateral 
lower limb arterial and venous examination was normal. 
There was no redness over feet, pedal edema or collateral 
formation over abdomen. Abdominal examination 
revealed mild lower abdominal tenderness without any 
hepatomegaly and ascitis. Rest of the systemic examination 
was unremarkable.
Hematological analysis confirmed normocytic anemia with 
hemoglobin 11.3 gm/dl, a raised erythrocyte sedimentation 
rate (ESR) (130 mm fall in the first hour), while the total 
and differential leukocyte counts were normal. C-reactive 
protein was elevated at 130 mg/L. Urine examination was 
normal. Biochemical parameters such as liver and kidney 
functions, and serum electrolytes, calcium, phosphorous, 
alkaline phosphatase and D-dimer were within normal limits. 
Electrocardiogram revealed left ventricular hypertrophy. 
The chest radiograph and echocardiogram were normal. 
The Endocrinological evaluation revealed increased urine 
catecholamines and urinary vanillyl mandelic acid (VMA) 
[Table 1]. Plasma cortisol and Adrenocorticotropic 
hormone (ACTH) were within normal limits.
Abdominal CT revealed a well defined, heterogenous 
mass lesion of size 7.6 × 5.3 × 4.8 cms with attenuation 
score of 35 HU at the upper pole of right kidney without 
any calcifications [Figure 1]. Ultrasound (USG) abdomen 
revealed normal renal and hepatic parenchyma. There was 
no involvement of renal vein, hepatic veins and veins of 
lower limbs demonstrated by doppler ultrasound. Magnetic 
resonance imaging (MRI) revealed intraluminal thrombus 
extending proximally up to the confluence of hepatic veins 
immediately inferior to the right atrium without distal 
extension to femoral veins bilaterally [Figure 2]. MRI also 
revealed compression of IVC. An IVC venogram via the 
right jugular vein demonstrated multiple filling defects 
indicating occlusion of the IVC inferior to the right atrium 
Figure 1: Computed tomography of the abdomen- showing a 
well defined, heterogeneously enhancing mass lesion of size 
7.6 × 5.3 × 4.8 cm at the upper pole of right kidney without any 
calcifications. The left adrenal gland appeared to be normal
Figure 2: T2-weighted axial magnetic resonance imaging demonstrating 
the mass (predominantly high signal) between the inferior vena cava 
and right kidney (black arrow) compressing the overlying inferior vena 
cava (white arrow)
Table 1: Baseline biochemical parameters of the patient
Parameters Values Normal range
Plasma rennin activity (ng/ml/h) 8.2 0.7-1.4
Plasma aldosterone (ng/dl) 61.2 2-20
24 hour urine fractionated 
metanephrines (mg/24 hrs)
53 <1.3
24 hour urine VMA (mg/24 hrs) 69 1-8
Plasma metanephrines (µg/dl) 285 <60
8.00 AM Plasma cortisol (µg/dl) 17.2 5-25
Plasma ACTH (pg/ml) 27.8 10-60
VMA: Vanillyl mandelic acid; ACTH: Adrenocorticotropic hormone
[Figure 3]. There was simultaneous enlargement of distal 
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Figure 4: The typical growth pattern of nests of tumor cells (zellballen) 
surrounded by a discontinuous layer of sustentacular cells and 
fibrovascular stroma in the biopsy specimen of the patient in the 
study. Blood vessels surrounding tumor nests are composed of round 
to oval cells
Figure 5: T2-weighted axial magnetic resonance imaging comparable 
in position and image acquisition to Figure 2 demonstrating complete 
resolution of inferior vena cava thrombosis (white arrow) after 4-months 
of oral anticoagulation therapy
A diagnosis of IVC thrombosis with pheochromocytoma 
was established, and surgical treatment was planned. Alpha 
receptor blocking therapy with prazosin was instituted, 
followed by β blocker, after testing for adequacy of 
α blockade. The patient was treated conservatively with 
subcutaneous low molecular weight heparin followed 
by oral warfarin. After 2 weeks, hypertension was well 
controlled and the remaining symptoms disappeared. With 
adequate blood pressure control, patient was subjected to 
laparoscopic adrenalectomy. There was no evidence of 
perilesional or distant invasions. Biopsy of the specimen 
revealed a typical organoid or zellballen pattern with 
no cytoplasmatic inclusion, pleomorphism, cytological 
alterations or necrosis; and, the mitotic index was low 
[Figure 4]. During the postoperative period, the blood 
pressure was normal, and the patient’s convalescence was 
uncomplicated. He was discharged on the 11th postoperative 
day. During the next 16 months, the patient’s blood pressure 
remained normal. A 24-hour urine specimen collected for 
metanephrine and VMA, revealed levels within normal 
limits. At present, the patient is asymptomatic, requires no 
medications, and is employed as an engineer. MRI imaging 
demonstrated resolution of the thrombosis and return of 
patency of the IVC at 4 months [Figure 5].
DISCUSSION
Two aspects render our case unusual: 1) the coexistence of 
pheochromocytoma with IVC thrombosis 2) Though there 
are case reports citing the association between malignant 
pheochromocytoma and IVC thrombus,[7,8] to our sincere 
belief; this is the first such report citing this uncommon 
association from India.
Although the lifetime incidence of venous thrombosis is 
0.1%, it still remains a rare condition especially in patients 
below 30 years of age.[9] Predisposing factors include 
alterations in blood flow [stasis], injury to the vascular 
endothelium and abnormalities in the constitution of 
blood hypercoagulability (Virchow’s Triad).[10] Endothelial 
damage is invariably an acquired phenomenon, whereas 
hypercoagulability may result from both congenital and 
acquired risk factors (especially in the peri-operative 
period). The classical presentation of IVC thrombus 
varies according to the level of the thrombosis with up to 
50% of patients presenting with bilateral lower extremity 
swelling and dilatation of superficial abdominal vessels. 
Whilst some patients remain asymptomatic, lower back 
pain, nephrotic syndrome, hepatic engorgement, cardiac 
failure and pulmonary embolus have also been described.  [11] 
Tsuji et al. reported a series of 10 patients where 40% were 
pyrexic at presentation, with an associated elevation in 
D-dimer levels and inflammatory markers (white cell count, 
C-reactive protein).[12] Our patient had no lower limb, liver 
or kidney involvement, and this might be ascribed to the 
partial occlusion of IVC. He only had elevated inflammatory 
markers. We could not explain normal D-dimer levels in the 
backdrop of such a large thrombus in our patient.
CT scan with contrast enhanced images and MRI scan 
are used to localize adrenal pheochromocytoma.[13] meta-
iodobenzylguanidine (MIBG) and Positron emission 
tomography (PET) scanning (Gallium- DOTA-toc/noc 
and DOPA-PET perform better than FDG- PET) are 
largely reserved for extraadrenal paraganglioma, or very 
large tumors to rule out metastasis. Heterogeneity, high 
hounsfield density on CT (>HU), marked enhancement Journal of Cardiovascular Disease Research Vol. 3 / No 2 163
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with intravenous contrast and delayed contrast washout 
(<60 % at 10 minutes), high signal intensity on T2 
weighted MRI, cystic and hemorrhagic changes point 
to pheochromocytoma, adrenocortical carcinoma or 
metastasis. However, pheochromocytoma with lipid 
degeneration can result in low attenuation scores (<10 HU) 
and >60% washout at delayed CT scanning.[14] Benign 
adrenal incidentalomas are characterized by size <5 cm, 
sharp margins, smooth contours, lack of demonstrable 
growth on serial examinations, attenuation scores 
<10 HU, and >60% washout at delayed CT scanning.  [13,15] 
In our patient, CT scan revealed nonhomogenous mass 
of HU 35 without any calcification. Histologically, 
pheochromocytomas are capsulated and are composed 
of round or polygonal epithelioid/chief cells arranged in 
characteristic compact cell nests (Zellballen) or trabecular 
patterns. The chief cells have centrally located nuclei 
with finely clumped chromatin, and a moderate amount 
of eosinophilic, granular cytoplasm. Spindle shaped 
sustentacular or supporting cells are located peripherally. 
Tumors of higher grade are characterized by a progressive 
loss in the relationship between chief cells and sustentacular 
cells, and a decrease in the number of sustentacular cells. In 
our patient, typical zellballen pattern was found. Presence 
of markers like chromogranin A (CGA), neuron specific 
enloase, synaptophsyin serve as additional tools to confirm 
the neuroendocrine nature of the chief cells.[16]
Malignant pheochromocytomas are histologically and 
biochemically similar to benign ones. The only reliable 
clue to the presence of a malignant pheochromocytoma 
is local invasion or distant metastases, which may occur 
as long as 20 years after resection.[17] Thus, even when 
pheochromocytomas or paragangliomas are considered 
“benign” on pathologic examination, long term follow-up 
is indicated in all patients to confirm that impression. Other 
markers for malignancy are absent or weak expression of 
inhibin/activin- beta B subunit,[18] and presence of succinate 
dehydrogenase B (SDH B) subunit is seen. In absence of any 
invasion, we considered the mass in our patient to be benign.
The simultaneous occurrence of pheochromocytoma and 
IVC thrombosis is reported sporadically. IVC thrombosis 
in this case could be because of: 1) local compression 
leading to alteration in blood flow and stasis 2) sustained 
hypertension leading to vascular endothelial injury and 
hypercoagulability, 3) association of pheochromocytoma 
with systemic lupus erythematous and Behcet’s disease 
might explain the triggering of an autoimmune 
phenomenon leading to a hypercoagulable state, and 
4) an underlying anatomic abnormality or coagulation 
disorder. It also could be a chance association between 
these 2 conditions. In our case, local compression due to 
coexisting pheochromocytoma might have been causative.
Recent advances in the utilization of ultrasound, CT 
and MRI imaging as well as endovascular procedures 
have resulted in an increase in detection rates of IVC 
anomalies, as well as an increase in the incidental discovery 
of such abnormalities during unrelated investigations, 
therapeutic endovascular or surgical procedures.[12] 
Contrast venography remains the standard for diagnosis 
of IVC thrombosis with a low false-positive rate, and the 
advantage of access for immediate treatment if required. 
However, it is an invasive procedure associated with a 
2%-10% incidence of post-procedural Deep venous 
thrombosis (DVT).[6] Duplex ultrasound scanning has 
become an accurate non-invasive method of diagnosing 
IVC thrombosis and is often the first-line investigative 
modality.[6] However, duplex USG is operator dependant 
and can be limited by body habitus or the presence of 
bowel gas and may occasionally fail to identify any IVC 
anomaly.[19] CT imaging is a rapid non-invasive method 
which can accurately diagnose and assess the extent of 
thrombus as well as delineate any associated abdominal 
or pelvic abnormality.[6] MRI imaging is now replacing CT 
as the optimal investigative tool avoiding radiation and 
giving more accurate delineation of thrombus as well as 
any IVC anomaly. MRI is also used to follow-up patients 
to determine morphological changes in the thrombus 
following therapy.[20]
Management of patients with coexisting pheochromocytoma 
and IVC thrombosis needs operative resection of the 
adrenal mass and medical/interventional management 
of IVC thrombosis. The goals of operation include 1) 
removal of the tumor with postoperative normotension, 
and 2) IVC luminal restoration and anticoagulation. 
Minimally invasive techniques are being increasingly used 
for resection of adrenal tumors and to treat renal artery 
lesions. Laparoscopic adrenalectomy is performed by 
either the transperitoneal or retroperitoneal approach.[21] 
Our patient was subjected to laparoscopic adrenalectomy 
after adequate preoperative blood pressure control by α 
blockers, followed by β blockers. Treatment options in the 
case of IVC thrombus without anatomical variance include 
anticoagulation, mechanical thrombectomy, systemic 
thrombolytic therapy, transcatheter regional thrombolysis, 
pulse-spray pharmacomechanical thrombolysis and 
angioplasty.[22] There is no specific literature describing 
the ideal duration of anticoagulation in these instances; 
however, case evidence identifies a trend toward treatment 
for a minimum of one year with the interplay of 
hypercoagulability disorders needing to be factored into any 164  Journal of Cardiovascular Disease Research Vol. 3 / No 2
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decision. Surgical reconstruction of the IVC and bypass of 
an aberrant section are both recognized modalities reserved 
for the most severe cases and are associated with morbidity 
and mortality risk.[23] Endovascular stent placement in 
combination with angioplasty is recommended in the cases 
of residual stenosis and chronic IVC occlusion.[23]
In the case of IVC thrombus associated with an aberrant 
IVC, with no other predisposing factors, treatment 
involves anti-coagulation. The duration of this treatment 
is widely debated with no extensive literature to provide 
an evidence based approach. Dean et al. took a view, which 
is quite similar to that of ours, that a caval anomaly is a 
permanent risk factor for venous stasis and thrombosis and 
that anticoagulant treatment should be lifelong.[24] Since 
our patient had no anatomic abnormality or any other 
predisposing factors, we decided to give the treatment 
for 4 months only and stopped it then after documenting 
radiologic luminal restoration.
CONCLUSION
Pheochromocytoma is known to be associated with vascular 
abnormalities. Though cases of renal artery stenosis, renal 
artery aneurysm and inferior vena cava thrombosis have 
been described, we found the uncommon association with 
IVC thrombosis in an Indian patient. IVC thrombosis is 
associated with a significant acute and chronic morbidity. 
A high index of suspicion is warranted for IVC thrombus. 
CT or preferably MRI imaging are required to delineate IVC 
anatomy and ascertain proximal extent of the thrombus. 
Although invasive therapeutic modalities exist, long-term 
and commonly life-long anticoagulation is often required. 
Pheochromocytoma does not seem to have any effect on 
the outcome of the coexisting IVC thrombosis. Our article 
calls for more research to confirm or refute the proposed 
hypothetical association.
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